Revier Invest Heidelberg

Revier Invest is a private investment and holding company based in Heidelberg, Germany, specializing in the life sciences and biotechnology sectors. The firm is led by Dr. Gero Hütter, the hematologist renowned for the Berlin Patient HIV cure, and focuses on supporting innovative healthcare ventures. Revier Invest provides strategic capital to companies developing advanced therapeutic modalities, including cell therapies and oncology treatments. Its investment activities are centered on translating scientific breakthroughs into clinical applications within the European biotech ecosystem. The company often acts as a founding investor or strategic partner for early-stage startups emerging from German academic and clinical research. Notable portfolio involvements include companies such as Cellex and GEMoaB, highlighting a focus on immunotherapy and specialized blood products.